JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Basora, N.
Right arrow Articles by Beaulieu, J.-F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Basora, N.
Right arrow Articles by Beaulieu, J.-F.

J Biol Chem, Vol. 274, Issue 42, 29819-29825, October 15, 1999


Expression of Functionally Distinct Variants of the beta 4A Integrin Subunit in Relation to the Differentiation State in Human Intestinal Cells*

Nuria BasoraDagger , F. Elizabeth Herring-Gillam, François BoudreauDagger , Nathalie Perreault§, Louis-Philippe Pageot, Mélanie Simoneau, Yamina Bouatrouss, and Jean-François Beaulieuparallel

From the Centre de Recherche en Biologie du Développement des Épitheliums et Thématique de Physiopathologie Digestive du Centre de Recherche Clinique du CUSE, Département d'anatomie et de biologie cellulaire, Faculté de médecine, Université de Sherbrooke, Sherbrooke, Québec, Canada J1H 5N4

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Integrins are important mediators of cell-laminin interactions. In the small intestinal epithelium, which consists of spatially separated proliferative and differentiated cell populations located, respectively, in the crypt and on the villus, laminins and laminin-binding integrins are differentially expressed along the crypt-villus axis. One exception to this is the integrin alpha 6beta 4, which is thought to be ubiquitously expressed by intestinal cells. However, in this study, a re-evaluation of the beta 4 subunit expression with different antibodies revealed that two forms of beta 4 exist in the human intestinal epithelium. Furthermore, we show that differentiated enterocytes express a full-length 205-kDa beta 4A subunit, whereas undifferentiated crypt cells express a novel beta 4A subunit that does not contain the COOH-terminal segment of the cytoplasmic domain (beta 4Actd-). This new form was not found to arise from alternative beta 4 mRNA splicing. Moreover, we found that these two beta 4A forms can associate into alpha 6beta 4A complexes; however, the beta 4Actd- integrin expressed by the undifferentiated crypt cells is not functional for adhesion to laminin-5. Hence, these studies identify a novel alpha 6beta 4Actd- integrin expressed in undifferentiated intestinal crypt cells that is functionally distinct.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Epithelial cells are characterized by special structural features such as polarized morphology, specialized cell-cell contacts, and their attachment to an underlying basement membrane (1). This attachment mediates various crucial cell functions including adhesion, migration, proliferation, differentiation, and cell survival. The biological effects of basement membranes are largely mediated by laminins, a growing family of structurally related molecules (2, 3), which are expressed in a tissue-specific manner (4). Epithelia bind to laminins via various cell membrane receptors, many of which are members of the integrin superfamily (5-9) which can subsequently initiate intracellular signaling cascades upon ligation to their ligand (10, 11). Some integrins, such as alpha 2beta 1 and alpha 3beta 1, are considered quite promiscuous (12) and bind various molecules including laminins, while others such as alpha 6beta 1, alpha 7beta 1, and alpha 6beta 4 are specific for laminins (8, 13).

The integrin alpha 6beta 4 has a number of features which distinguish it structurally and functionally from the other laminin receptors of the beta 1 family (14-16). The beta 4 subunit has an unusually long cytoplasmic domain having no homology with other integrin beta  subunits. Upon binding to laminin-5, alpha 6beta 4 becomes concentrated in hemidesmosomes and is associated with intermediate filaments, making it essential for the organization and maintenance of the epithelial structure (17-19). This role was confirmed using transgenic mice in which the beta 4 subunit had been knocked out (20, 21), causing the loss of hemidesmosomal structures. Furthermore, mice carrying a targeted deletion of the integrin beta 4 cytoplasmic domain showed defects in both cell adhesion and proliferation (22), suggesting that beta 4 coordinates hemidesmosome assembly but may be responsible for additional signals, some of which may be essential for cell survival and cell cycle regulation (22, 23). Indeed, upon ligation to laminin-5, alpha 6beta 4 has been shown to become phosphorylated and to cause recruitment of Shc and Grb2-mSOS, which go on to activate Ras/MAP kinase pathways (17, 24).

The intestinal epithelium, which is in constant and rapid renewal, represents an interesting model for the study of mechanisms involved in the determination of the cell state (25). Within its functional unit, the crypt-villus axis, are two main distinct cell populations: the proliferative and poorly differentiated crypt cells and the mature enterocytes of the villus (26-28). Processes of epithelial cell growth and functional differentiation need to be tightly regulated along the crypt-villus axis (29, 30). Analysis of integrins and basement membrane molecules in the human intestine has revealed particular patterns of expression for many of these molecules, namely those involved in laminin-cell interactions (13, 25). Of interest is the reciprocal expression of laminin-1 and laminin-2 that has been found along the crypt-villus axis, with laminin-1 occurring as a villus form and laminin-2 as a crypt form, suggesting a relation between laminin form expression and cell differentiation (31, 32). The functional relevance of these observations was provided by the demonstration that laminin-1, but not laminin-2, can precociously induce differentiation in intestinal cells (33), suggesting that laminin-1 is critical in triggering terminal enterocytic differentiation (33, 34). A differential crypt-villus pattern of expression for laminin-binding integrins was also reported in the intestinal epithelium. The distribution of alpha 2beta 1 was mainly restricted to the crypt while alpha 3beta 1 was found predominantly in the villus (35, 36). More recently, alpha 7Bbeta 1, a specific laminin receptor largely involved in muscle development in response to laminin (37) has been identified in the intestinal epithelium. It was found to be located at the crypt-villus junction in the intact intestine while its expression was transiently up-regulated in differentiating enterocytes (38). In contrast, the integrin alpha 6beta 4 has been reported to be present at the base of intestinal epithelial cells all along the crypt-villus axis suggesting that this laminin receptor is ubiquitously expressed by intestinal cells (31, 32, 36, 39).

In this study, the expression of the beta 4 subunit in intestinal cells was re-evaluated on the basis of the observation that antibodies directed to the COOH-terminal segment of the cytoplasmic domain of the molecule (40) detected the beta 4 subunit only in the villus cells of the intact small intestine, suggesting that two distinct forms of beta 4 may exist in the intestinal epithelium. To further investigate this, we used two well characterized intestinal cell models which allow to some extent the recapitulation of the crypt-villus axis in vitro: the crypt-like HIEC cells, which are proliferative and undifferentiated (41), and the Caco-2/15 cells which have the ability to differentiate into fully functional villus-like enterocytes (42-44). Our data show that differentiated enterocytes express a full-length 205-kDa beta 4A subunit while undifferentiated crypt cells express a novel beta 4A subunit which does not contain the COOH-terminal segment of the cytoplasmic domain (beta 4Actd-). Moreover, we found that these two beta 4A variants form alpha 6beta 4A complexes that are functionally distinct with regard to adhesion activity, the alpha 6beta 4Actd- receptor expressed on undifferentiated crypt cells being inactive as opposed to the fully functional alpha 6beta 4A integrin expressed on differentiated villus cells.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Tissues-- Specimens of adult small intestine (jejunum) were obtained from non-diseased parts of resected segments. Only specimens obtained rapidly were used; the overall period required before freezing the tissue after surgery never exceeded 60 min. The project was in accordance with the protocol approved by the Institutional Human Research Review Committee for the use of human material.

Cell Culture-- The human colon carcinoma Caco-2/15 cell line, a stable clone of the parent Caco-2 cell line (HBT 37; ATCC, Rockville, MD) has been characterized elsewhere (42-44). These cells are unique in that upon reaching confluence they spontaneously undergo a gradual enterocytic differentiation process, similar to that observed in the epithelium of the intact fetal small and large intestine (42-45). Cells between passages 53 and 70 were cultured in plastic dishes (100 mm Falcon, Becton-Dickinson Labware, Mississauga, Ontario, Canada) at 37 °C in an atmosphere of 95% air, 5% CO2, in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (CELLect Gold, ICN/Flow, Costa Mesa, CA), 4 mM glutamine, and 20 mM HEPES and cultures were refed every 48 h.

The HIEC-6 cells have been generated from the normal fetal human small intestine. These cells express a number of crypt cell markers but no villus cell markers and are thus considered as poorly differentiated crypt cells (41, 46). They were grown in Dulbecco's modified Eagle's medium supplemented with 4 mM glutamine, 20 mM HEPES, 5 ng/ml recombinant epidermal growth factor (Life Technologies, Inc.), 0.2 IU/ml insulin (Connaught Novo Laboratories, Willowdale, Ontario), and 5% fetal bovine serum in 100 mM plastic culture dishes (41). Cells were used between passages 5 and 15.

Primary Antibodies-- Antibodies used in this study were the monoclonals GoH3 (Ref. 47; Pharmingen, Mississauga, Ontario) against the extracellular domain of the alpha 6 integrin subunit and 3E1 (Ref. 48; Life Technologies, Inc., Burlington, Ontario) and 439-9B (Pharmingen) both against the extracellular domain of the beta 4 integrin subunit; mAb13 against integrin beta 1 and mAb16 against integrin alpha 5 were kind gifts from Dr. S. K. Akiyama (Ref. 49; National Institute of Dental Research, Bethesda, MD); P1E6 against integrin alpha 2 (Ref. 12; Life Technologies, Inc.); and P1B5 against integrin alpha 3 (Ref. 12; Oncogene Science, Uniondale, NY). An anti-beta 4 antiserum (40) raised against the last 31 amino acids of the cytoplasmic terminal domain of the beta 4 subunit (referred to hereafter as the anti-beta 4c antibody) was generously provided by Dr. E. Ruoslahti (The Burnham Institute, La Jolla, CA). Another anti-beta 4 antiserum (AB1922; Chemicon International, Mississauga, Ontario) directed toward the last 20 amino acids of the COOH-terminal domain of the beta 4 subunit was also used for immunolocalization studies. Purified laminin-5 was a generous gift from Dr. R. Burgeson (Cutaneous Biology Research Center, Charlestown, MA).

Indirect Immunofluorescence-- The preparation and Optimum Cutting Temperature embedding compound (Tissue Tek, Miles laboratories, Elkhart, IN) embedding of tissue samples for cryosections was performed as described previously (35). Frozen sections 3-µm thick were cut on a Jung Frigocut 2800N cryostat (Leica Canada, St. Laurent, Québec), spread on silane-coated glass slides, and air-dried 1 h at room temperature. Tissue sections were fixed in methanol or ethanol (10 min, -20 °C) before immunostaining, as described elsewhere (31, 35). Primary antibodies were diluted 1/100 (anti-beta 4cyto and AB1922) or used at 5 µg/ml (3E1 and 439-9B). The secondary antibody was an fluorescein isothiocyanate-conjugated goat anti-rabbit or anti-mouse IgG (Roche Molecular Biochemicals Canada, Laval, Québec) or anti-rat IgG (Caltag, Cedarlane Laboratories, Hornby, Ontario) used 1/25 in 2% bovine serum albumin in PBS.1 Sections were stained with 0.01% Evan's blue in PBS, mounted in glycerol-PBS (9:1) containing 0.1% paraphenylenediamine, and viewed with a Reichart Polyvar 2 microscope (Leica Canada) equipped for epifluorescence. In all cases no specific immunofluorescent staining was observed when primary antibodies were omitted or replaced by the corresponding non-immune serum.

Gel Electrophoresis and Immunoblotting-- Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on 10% acrylamide gels and immunoblotting were performed as described previously (33, 41, 42). Cells were washed twice in PBS and harvested in 1 × solubilization buffer (2.3% SDS, 10% glycerol, 0.001% bromphenol blue in 62.5 mM Tris-HCl, pH 6.8) containing 5% beta -mercaptoethanol. Samples were boiled for 5 min, cleared by centrifugation (13,000 × g, 5 min), and aliquoted for storage at -80 °C. Separated proteins (100 µg/lane) were transferred onto nitrocellulose (Bio-Rad, Mississauga, Ontario) and blocked in PBS containing 10% powdered skim milk, then incubated overnight at room temperature with primary antibodies (anti-beta 4c, 1/500) diluted in the blocking solution. Alkaline phosphatase-conjugated secondary antibodies (Bio-Rad) were used according to the manufacturers instructions.

Metabolic Cell Labeling and Immunoprecipitation-- Cells were metabolically labeled using Promix [35S]methionine and cystine (Amersham Pharmacia Biotech), 100 µCi/ml for HIEC and 200 µCi/ml for Caco-2/15 for the indicated times as described previously (50). For certain points, cells were labeled as described above and after the labeling period the radioactive medium was removed, cells were washed once with complete Dulbecco's modified Eagle's medium, and chased with 10 ml of complete Dulbecco's modified Eagle's medium containing 10 × methionine and 10 × cystine for the indicated times. Cells were solubilized in ice-cold lysis buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 0.5% Triton X-100, 2 µM phenylmethylsulfonyl fluoride, 50 µg/ml leupeptin, 50 µg/ml pepstatin, 100 µg/ml aprotinin) for 20 min on ice, then centrifuged for 15 min at 13,000 × g. Samples were pre-cleared using 100 µl of heparin-agarose (Bio-Rad) followed by 50 µl of protein G-Sepharose (Life Technologies, Inc.) each for 1 h at 4 °C. Antibodies were added to the samples and incubated for 15 h at 4 °C followed by the addition of protein G-Sepharose for 1 h at 4 °C. Radioactive samples were analyzed under nonreduced conditions by SDS-PAGE, the gels were fixed (10% acetic acid, 45% methanol, 45% deionized water) for 1 h and soaked for 15 min in Amplify (Amersham Pharmacia Biotech), dried and exposed using Hyperfilm ECL (Amersham Pharmacia Biotech).

RT-PCR-- Total RNA was isolated from cell lines or tissue homogenates using TriZOL (Life Technologies, Inc.). The integrity of the RNA was verified by ethidium bromide staining and the quantities were determined spectrophotometrically. Reverse transcriptase Superscript (Life Technologies, Inc.) and 0.5 µg of oligo(dT)12-18 primer (Amersham Pharmacia Biotech) were added to 5 µg of total RNA, as described elsewhere (51). The integrin beta 4 subunit was amplified using five different sets of primers. B1/B2: B1 (5'-GAATTCGTTCTACGCTCTCC-3') and B2 (5'-GAATTCTGAGAGATGTGGGC-3') amplify a band of 369 bp which spans the region 4182 to 4551 of beta 4A (14). B3/B4: B3 (5'-CCCGGGGATATCGTCGGCTAC-3') and B4 (5'-CCCGGGGCTGTCTCCATCCAC-3') amplify a band of 83 bp (52) spanning the region of 4921 to 5004 bp of beta 4A; B5/B6: B5 (5'-GAATTCTTCCTAGTGGATGG-3') and B6 (5'-GAATTCCTAGTGGGACAT-3') amplify a band of 186 bp spanning the region of 5235 to 5421 of beta 4A; B7/B8: B7 (5'-TCTCCGATGACACTGAGCAC-3') and B8 (5'-GTAGCCGACGATATCCCCAT-3') amplify a band of 718 bp spanning the region of 4220-4938 of beta 4A; B9/B10: B9 (5'-CCCATGAAGAAAGTGCTGGT-3') and B10 (5'-TCCATCCTGGGACTCTATGG-3') amplify a band of 1202 bp spanning the region of 3931 to 5133 of beta 4A. Single-stranded cDNA was amplified in PCR buffer (Amersham Pharmacia Biotech) containing 0.25 µM of both sense and antisense primers for 30 cycles of denaturation (1 min at 94 °C), annealing (1 min at 55 °C for B1/B2, B7/B8, and B9/B10, 65 °C for B3/B4, and 51 °C for B5/B6 and B3/B6), and extension (1 min at 72 °C) in a thermal cycler (Perkin-Elmer DNA Thermal cycler model 480) in the presence of 250 µM dNTPs and 2.5 units of Taq (Roche Molecular Biochemicals; obtained from Amersham Pharmacia Biotech). Conditions for S14 amplification and sequence analysis of the beta 4 B3/B6 PCR products were described elsewhere (38). The beta 4 B9/B10 1202-bp PCR product was digested with SmaI and SacII prior to cloning in pBluescript for sequence analysis.

Cell Adhesion Assays-- The adhesion of HIEC and Caco-2/15 cells on laminin-5 was carried out in 96-well plates based on a procedure described previously (53). Bovine serum albumin, 1%, was used to set background binding. Purified laminin-5 was used at 10 µg/ml. The wells were coated for 1 h at 37 °C and subsequently blocked with 0.25% bovine serum albumin for 1 h at 37 °C. Cells harvested using 10 mM EDTA, washed twice, and 5 × 104 cells were plated per well for 30 min. Unbound cells were removed by gently washing twice with PBS and bound cells were fixed in 1% formaldehyde, colored with a 1% crystal violet solution, and solubilized using 2% SDS. The plates were read at 595 nm with a Microplate Reader (model 3550, Bio-Rad). For inhibition studies, neutralizing antibodies were added to cells before plating and incubated for 30 min, each at a final concentration of 10 µg/ml.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

As shown previously with the 3E1 antibody (31, 36) and confirmed herein by using 439-9B, another antibody directed to the extracellular domain of the molecule, the beta 4 subunit was found to be expressed in significant amounts at the base of all epithelial cells in both crypt and villus (Fig. 1A). The use of another antibody, the anti-beta 4c, raised against the last 31 amino acids of the COOH-terminal of the beta 4 subunit, produced a distinct pattern of expression by strongly labeling the basal surface of villus cells but not the crypts (Fig. 1B). The specificity of the staining pattern of the anti-beta 4c antibody was confirmed with AB1922, another antibody directed against the last 22 amino acids of the COOH-terminal of the beta 4 subunit (Fig. 1C). This observation suggests that at least two immunologically distinct forms of beta 4 exist in the intestinal epithelium and that they are associated with different cell populations along the crypt-villus axis.


View larger version (99K):
[in this window]
[in a new window]
 
Fig. 1.   Different patterns of expression for the beta 4 subunit using specific antibodies. Indirect immunofluorescence on normal adult human small intestine using (A) 439-9B against the extracellular domain and the anti-beta 4c (B) and AB1922 (C) both directed toward the cytoplasmic terminal domain of the beta 4 subunit. All primary antibodies were detected using fluorescein isothiocyanate-conjugated secondary antibodies.

Expression of beta 4 in Intestinal Epithelial Cells-- This hypothesis was tested by analyzing the expression of the beta 4 subunit in undifferentiated (HIEC) and differentiated (Caco-2/15) cells. Western blot analysis of cell lysates using anti-beta 4c (Fig. 2A) detected the beta 4 subunit in Caco-2/15 (lane 2) cells but not in HIEC cells (lane 1). However, RT-PCR amplification using two different sets of primers, located in the region encoding for the cytoplasmic domain of beta 4, revealed that both cell models express the beta 4 transcript (Fig. 2B, lanes 2 and 4). The B1/B2 primer set spans the region which is alternatively spliced to produce isoforms beta 4A, beta 4B, or beta 4C (15, 16, 40). This set of primers amplifies a band of 369 bp which corresponds to beta 4A, indicating that this is the major beta 4 isoform in both cell lines. The primer set B3/B4 has been used previously to identify the beta 4D isoform which contains a 21-bp deletion (52). The amplification of a single band of 83 bp with this set of primers in HIEC and Caco-2/15 cells indicated that neither cell line expresses this isoform.


View larger version (65K):
[in this window]
[in a new window]
 
Fig. 2.   Detection of the beta 4 subunit in HIEC and Caco-2/15 cells. A, immunoblot analysis using anti-beta 4c on HIEC (lane 1) and Caco-2/15 cell (lane 2) lysates (100 µg/lane) separated on a 10% SDS-PAGE detected the presence of the beta 4 subunit, at its known molecular mass of 205 kDa, only in the Caco-2/15 cells. B, RT-PCR analysis using two different primer sets (see "Experimental Procedures"), B1/B2 (373 bp) and B3/B4 (93 bp) amplified identical bands in reverse transcribed mRNA (+) from both HIEC (lane 2) and Caco-2/15 cells (lane 4). S14 was used to ensure comparable quantities of starting material. -, no RT.

Undifferentiated Crypt Cells Contain a Novel Form of the beta 4A Subunit-- The differential expression of beta 4 subunits between differentiated and undifferentiated intestinal cells was further investigated by immunoprecipitation using the 3E1 antibody, followed by Western blot detection using the anti-beta 4c antibody (Fig. 3A). As expected from Western blot analyses (previous section), the beta 4 subunit was only detected in Caco-2/15 cells (lane 2) with this procedure, suggesting that the beta 4c epitope is absent in HIEC. To verify this, HIEC and Caco-2/15 cells were metabolically labeled using [35S]methionine and cystine for 6 h, then beta 4 was immunoprecipitated using either 3E1 or the anti-beta 4c antibody. As shown in Fig. 3B, both antibodies immunoprecipitated comparable amounts of the beta 4 subunit in Caco-2/15 cells, demonstrating that both 3E1 and anti-beta 4c epitopes are expressed in these cells (Fig. 3B, lanes 3 and 4). In HIEC, however, the beta 4 subunit was detected as a 205-kDa band using 3E1 (lane 2) while the anti-beta 4c failed to immunoprecipitate the protein (lane 1), indicating that HIEC express the beta 4 subunit, but under a form which lacks the beta 4c epitope, thus distinct from the beta 4 subunit found in Caco-2/15 cells.


View larger version (48K):
[in this window]
[in a new window]
 
Fig. 3.   HIEC contain a novel form of the beta 4A subunit. A, immunoprecipitation of the beta 4 subunit using 3E1 from equal quantities (3 mg of protein) of HIEC (lane 1) and Caco-2/15 cells (lane 2) followed by separation on a 10% SDS-PAGE and immunodetection using the anti-beta 4c. B, immunoprecipitation using either the anti-beta 4c (lanes 1 and 3) or 3E1 (lanes 2 and 4) from HIEC (lanes 1 and 2) and Caco-2/15 (lanes 3 and 4) cells metabolically labeled using [35S]methionine and cystine for 6 h. Samples were separated on a 10% SDS-PAGE and the gel was dried and exposed for 48 h.

It has been previously reported that the beta 4 subunit can undergo proteolytic cleavage in its cytoplasmic tail (40, 54, 55). The possibility that this occurred in undifferentiated crypt cells was investigated by pulse-chase experiments and sequential immunoprecipitation. HIEC and Caco-2/15 cells were metabolically labeled with [35S]methionine and cystine for 2 h and chased for 0-8 h before lysis (Fig. 4A). For each sample, the beta 4 subunit was first immunoprecipitated using anti-beta 4c antibody. Then, after two additional rounds of immunoprecipitation with anti-beta 4c to ensure complete depletion of the immunoreactive beta 4c form in the samples, the remaining beta 4 was isolated with a last immunoprecipitation using the 3E1 antibody. This sequential immunoprecipitation procedure showed that in Caco-2/15 cells, the anti-beta 4c identified a major band at 205 kDa at all time points corresponding to the beta 4 subunit (Fig. 4A, upper left-hand panel). Subsequent immunoprecipitation of the beta 4c-depleted lysates using 3E1 indicated that the majority of the beta 4 subunit contains the anti-beta 4c epitope since very little material was recovered with 3E1 (Fig. 4A, upper right-hand panel). In contrast, in undifferentiated HIEC cells, beta 4 was barely detected after immunoprecipitation using the anti-beta 4c (Fig. 4A, lower left-hand panel), even with a chase time of 0 min, the almost complete majority of the beta 4 subunit being recognized only by 3E1 (Fig. 4A, lower right-hand panel). Shortening the labeling period down to 30 min (Fig. 4B) did not allow the detection of the beta 4 protein containing the anti-beta 4c epitope (Fig. 4B, left-hand panel), again the majority of the beta 4 subunit present being recognized only by 3E1 (Fig. 4B, right-hand panel). This indicates that in HIEC cells, the loss of the beta 4c epitope in the beta 4 precursor occurs extremely rapidly.


View larger version (84K):
[in this window]
[in a new window]
 
Fig. 4.   Identification of the major form of beta 44 expressed in HIEC and Caco-2/15 cells. A, HIEC (lower panels) and Caco-2/15 cells (upper panels) were metabolically labeled using [35S]methionine and cystine for 2 h and chased for 0 min (lanes 1 and 5), 1 h (lanes 2 and 6), 3 h (lanes 3 and 7), or 8 h (lanes 4 and 8). Cells were lysed in a nondenaturing buffer and immunoprecipitated using the anti-beta 4c (lanes 1-4). After two successive rounds of depletion with the anti-beta 4c, the remaining beta 4 was then immunoprecipitated from the same lysates using 3E1 (lanes 5-8). Samples were migrated on 10% SDS-PAGE under nonreducing conditions. The beta 4 subunit migrates at 205 kDa and the alpha 6 subunit migrates at 150 kDa. B, HIEC were labeled using [35S]methionine and cystine for 30 min with chase times of 0 min (lanes 1 and 4), 30 min (lanes 2 and 5), or 1 h (lanes 3 and 6). Cells were lysed in a nondenaturing buffer and immunoprecipitated using anti-beta 4c (lanes 1-3). After immunodepletion with the anti-beta 4c, the remaining lysates were then immunoprecipitated for a last round using 3E1 (lanes 4-6). All samples were separated on a 10% SDS-PAGE under nonreducing conditions and the gels were dried and exposed for 72 h.

The possibility that the beta 4 transcript may not code for the COOH-terminal domain in undifferentiated crypt cells was verified by designing primers (B5/B6; see "Experimental Procedures") for RT-PCR that would amplify the region overlapping the nucleotides encoding the last 30 amino acids against which the anti-beta 4c antibody was raised. As shown in Fig. 5, both cell lines expressed a beta 4A transcript that contains this sequence. To rule out the possibility that the lack of the beta 4c epitope in undifferentiated crypt cells arises from alternative splicing, the sequence of a large section of the beta 4 mRNA expressed by these cells was determined. Sequencing of the HIEC B3/B6 and B9/B10 PCR products (Fig. 5), which correspond to the last 1490 bp of the beta 4 mRNA encoding the carboxyl-terminal end of the protein, did not reveal any difference with beta 4A (14). Hence, altogether these results indicate that undifferentiated crypt cells express a novel form of the beta 4A integrin subunit which is distinct in its COOH-terminal domain from that found in differentiated intestinal cells.


View larger version (80K):
[in this window]
[in a new window]
 
Fig. 5.   The 3' end of the HIEC beta 4 transcript is identical to that of beta 4A. RT-PCR analysis using three different primer sets (see "Experimental Procedures"), B5/B6 (185 bp), B3/B6 (500 bp), and B9/B10 (1202 bp), amplified identical bands from reverse transcribed mRNA (+) from both HIEC (lane 2) and Caco-2/15 cells (lane 4). The sequences of the bands amplified with B3/B6 and B9/B10, which correspond to the last 1490 bp of the beta 4 mRNA, were confirmed and found to be identical to the human mRNA encoding beta 4A.

The alpha 6beta 4Actd- Complex in Intestinal Crypt Cells Is Not Functional-- As shown in Fig. 4A, the co-immunoprecipitation of alpha 6 with its beta 4A partner in both HIEC (with 3E1) and Caco-2/15 cells (with the anti-beta 4c) indicates that beta 4A is expressed in association with alpha 6 in both cell lines. The alpha 6beta 4 integrin serves as a specific receptor for laminins, namely laminin-5 (17, 18, 53, 56-58). Adhesion of HIEC and Caco-2/15 cells to laminin-5 was thus analyzed (Fig. 6). Adhesion of Caco-2/15 cells was partially inhibited by the GoH3 (anti-alpha 6) or 3E1 (anti-beta 4) antibodies. When both of these antibodies were used in combination, they significantly inhibited cell adhesion, indicating that the alpha 6beta 4A complex modulates substantially Caco-2/15 cell adhesion to laminin-5 in these cells. The mAb13 (anti-beta 1) antibody also significantly impaired laminin-5 binding, suggesting that Caco-2/15 cells may use a beta 1 integrin in cooperation with alpha 6beta 4A, but one other than alpha 2beta 1 or alpha 3beta 1 since the neutralizing antibodies P1E6 (anti-alpha 2) and P1B5 (anti-alpha 3), alone or in combination with GoH3, failed to affect significantly Caco-2/15 cell adhesion to laminin-5. In contrast, HIEC cell binding to laminin-5 was unaffected in the presence of GoH3 or 3E1, either alone or in combination, suggesting that alpha 6beta 4Actd- is not functional. However, HIEC cells appear to use alpha 3beta 1 instead, another laminin-5 receptor, since adhesion is markedly inhibited with P1B5 or mAb13. In combination, P1B5 and GoH3 did not increase inhibition, supporting the interpretation that alpha 6beta 4Actd- is not involved in the binding of undifferentiated intestinal cells to laminin-5.


View larger version (41K):
[in this window]
[in a new window]
 
Fig. 6.   The alpha 6beta 4Actd- integrin is not a functional receptor for laminin-5 in undifferentiated HIEC cells. Adhesion of HIEC and Caco-2/15 cells on purified laminin-5 (10 µg/ml) in the presence of neutralizing antibodies to alpha 2 (P1E6), alpha 5 (mAb16), alpha 3 (P1B5), alpha 6 (GoH3), beta 1 (mAb13), and beta 4 (3E1) integrin subunits, either alone or in the following combinations: alpha 2 + alpha 6, alpha 3 + alpha 6, and alpha 6 + beta 4. All antibodies were added to the cells at 10 µg/ml and incubated for 30 min before plating. Results are from four separate experiments and are expressed as the percentage of cells bound after 30 min, with 100% being adhesion on laminin-5 in the absence of antibodies (n = 4).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Epithelial cell proliferation, migration, and differentiation are tightly regulated along the crypt-villus axis of the small intestine and evidence that cell-laminin interactions play a role in their regulation is strengthening (33, 34). As in other systems, cell-laminin interactions are highly dynamic in the renewing intestinal epithelium, a differential expression of both receptors and ligands having been observed along the crypt-villus axis (13, 25). In the present study, we have examined the function of the alpha 6beta 4 integrin in the mediation of intestinal cell-laminin interactions. We have identified two distinct forms of the beta 4 subunit expressed according to the cell state in the intestinal epithelium: a previously undescribed variant of beta 4A that lacks a small terminal fragment of the cytoplasmic domain (beta 4Actd-), which is expressed by crypt cells and their normal in vitro counterpart, the HIEC cells, and the full-length beta 4A subunit, which is expressed by Caco-2/15 cells and by villus cells in the intact intestine. Our results provide clear evidence that both variants of beta 4A can associate with the alpha 6 subunit to form a stable alpha 6beta 4A complex. However, in contrast to the alpha 6beta 4A present in differentiated intestinal cells, the alpha 6beta 4Actd- expressed by undifferentiated crypt cells was found to be non-functional for cell adhesion to laminin-5.

The beta 4 subunit can exhibit a high degree of structural complexity resulting from alternative splicing of its mRNA as well as proteolytic cleavage. Up to now, five distinct mRNA variants of the human beta 4 integrin have been identified, each altering the cytoplasmic domain, and designated (59) beta 4A, which is the most common form (14), beta 4B (15), beta 4C (16), beta 4D (52), and the newly identified beta 4E (60). Information about the distribution of these variants is still limited (16, 52) and the implication of their expression has only begun to be investigated at the functional level (59, 61). Analysis of these variants in intestinal epithelial cells by RT-PCR using specific primer sets revealed that both undifferentiated and differentiated cells express mainly, if not exclusively, the beta 4A form. Furthermore, RT-PCR with primers designed to amplify the 3' end of the beta 4A transcript encoding the anti-beta 4c epitope ruled out the possibility that the beta 4Actd- form observed in undifferentiated cells arises from an alternative splicing mechanism.

The expression of a beta 4A subunit lacking the immunoreactive terminal portion of the cytoplasmic domain may thus result from alteration(s) of the protein itself. Conformation changes are unlikely since the anti-beta 4c antibody used in this study is a polyclonal serum raised against a 31-amino acid stretch (40), and lack of the anti-beta 4c epitope was observed under both denaturing and nondenaturing conditions (see Figs. 2 and 3 for comparison). However, post-translational proteolytic cleavage in the cytoplasmic domain of the beta 4 subunit has been previously reported yielding a characteristic pattern of additional bands migrating at 165 and 125/130 kDa (40, 54, 55). These proteolytic fragments of beta 4 were not detected in either HIEC or Caco-2/15 cell extracts prepared under conditions in which proteolysis was inhibited (Refs. 40 and 55; see "Experimental Procedures"), indicating that such proteolysis does not occur in these cells. Furthermore, immunofluorescent cytoplasmic staining of the beta 4 subunit, used as an indicator of endogenous proteolysis in the intact tissue (40), was not observed in the intestinal epithelium. These observations suggest that such post-translational proteolytic cleavage of beta 4 does not occur significantly in the human intestinal epithelium. Since the lack of the anti-beta 4c epitope seems to be the result of proteolysis, it is likely to take place by a distinct mechanism. First, the actual portion of the cytoplasmic tail that appears to be deleted in beta 4Actd- would be very short since no significant difference was observed in the apparent size of beta 4Actd- from HIEC cells as compared with the full-length beta 4A isolated from Caco-2/15 cells. Second, its proteolysis should occur very rapidly in the biosynthetic pathway, i.e. co-translationally, since a beta 4A bearing the anti-beta 4Ac epitope was not detected in HIEC even after only 30 min of labeling. Taken together, these data indicate that undifferentiated intestinal cells constitutively express beta 4Actd-, a form of beta 4A that lacks a short portion of the terminal cytoplasmic domain. The exact mechanism involved in the generation of the beta 4Actd- form remains to be elucidated but our observations suggest that it arises from a co-translational processing of the integrin subunit.

A second interesting observation is that even though the beta 4A subunit was able to associate with its alpha 6 partner in the two cell lines studied, the alpha 6beta 4Actd- complex expressed by undifferentiated HIEC cells was found to be inactive in terms of laminin-5 adhesion. The HIEC do bind to laminin-5 but use the alpha 3beta 1 integrin, which has also been reported to have a high affinity for this ligand (8, 62, 63). Interestingly in these cells, alpha 3beta 1 appears to function without the cooperation of alpha 6beta 4Actd- since the combination of neutralizing antibodies to alpha 3 and alpha 6 did not inhibit adhesion of laminin-5 significantly more than anti-alpha 3 alone. In a recent study, it has been suggested that alpha 3beta 1 and alpha 6beta 4 can function cooperatively to mediate adhesion (64). This was not observed in HIEC adhesion to laminin-5 even when incubation times were extended to over 1 h (not shown), which is consistent with the apparent inability of alpha 6beta 4Actd- to bind to laminin-5. This lack of activity was surprising in view of the fact that tail-less beta 4 mutants (65, 66) can still bind to laminin-5, albeit at a lower affinity. However, this is not without precedent since a role for the COOH-terminal end of various other beta  subunit in integrin-mediated adhesion is well documented (67-70). In this context, the relation between an apparently minor alteration in the COOH-terminal domain of the beta 4Actd- subunit in undifferentiated intestinal crypt cells and the lack of activity of its alpha 6beta 4 complex is of particular interest. Indeed, the cytoplasmic domain of beta 4 is composed of distinct structural regions, namely two pairs of type III fibronectin-like modules separated by a region referred to as the connecting segment and the COOH-terminal segment. Both type III fibronectin-like modules and the connecting segment were shown to be important for hemidesmosome assembly including recruitment of HD-1/plectin, BP180, and the association with the keratin cytoskeleton (17, 59, 61, 66, 71-73). However, recent evidence indicates that the COOH-terminal segment of beta 4 also plays a key role in these interactions, being involved in the beta 4 interaction with HD1/plectin (72), BP180 (73), and itself (72, 73). This latter observation that the COOH-terminal end of beta 4 can bind directly to a more NH2 terminally located region, which encompasses the sequences essential for the interaction with other hemidesmosomal components, is particularly interesting as it suggests that the cytoplasmic domain of beta 4 can fold back upon itself and thus be part of a mechanism regulating beta 4 interactions with HD1/plectin and PB180 (73). Further characterization of the COOH-terminal end may reveal an additional role(s) for this beta 4 cytoplasmic segment. For instance, the functional significance of the strong phosphorylation of the COOH-terminal region of beta 4 reported in various epithelial cell lines (74, 75) remains to be determined while a number of interesting features pertaining to the cytoplasmic portion of the beta 4 subunit such as the recruitment of Shc/Grb2-mSOS and subsequently activating the Ras/MAP kinase pathways (17, 24), the ability to modulate the cyclin-dependent kinase inhibitors p21WAF/Cip1 and p27Kip (22, 65), as well as the activation of the phosphatidylinositol 3-OH kinase (76), have not yet been mapped.

What would be the biological relevance for undifferentiated crypt cells to express a alpha 6beta 4Actd- complex unable to mediate adhesion to laminin? While further investigations will be required to clearly answer this question, it is interesting to note that the epithelial basement membrane in the crypt region is negative for laminin-5 in the human small intestine, while it is expressed in the villus basement membrane (39, 77),2 and therefore coincides almost perfectly with the pattern of beta 4Actd+ expression. Furthermore, the expression of HD1/plectin has also been reported to be exclusively expressed by villus intestinal cells (77). The repression of laminin-5 and HD1/plectin expression, coupled to the production of an inactive alpha 6beta 4Actd- integrin, may thus represent two distinct control mechanisms ensuring that type II hemidesmosomes will not form in undifferentiated intestinal cells. It is noteworthy that the expression of an inactive form of a molecule is not without precedent in human intestinal crypt cells. For instance, sucrase-isomaltase, a brush-border hydrolytic enzyme, is the subject of a post-translational regulatory mechanism that depends on the state of differentiation for the acquisition of its mature fully active form (50). On the other hand, the lack of laminin binding activity of the alpha 6beta 4Actd- complex in the intestinal crypt may be of some importance, because of the presence of laminin-2 which is distributed according to an increasing gradient from the upper half to the bottom of the gland (31). Indeed, in addition to laminin-1 and laminin-5, which are restricted to the villus, laminin-2 can also serve as a ligand for alpha 6beta 4 (8, 23, 66). Therefore, it could be speculated that the inactivity of this receptor in terms of laminin binding is required to allow enterocytes to migrate upward to the villus. Finally, in light of the recent evidence that alpha 6beta 4 may exert biological activities in conditions where the interaction with its ligand does not occur (65, 78), the alpha 6beta 4Actd- complex present in crypt cells may nevertheless exert ligand independent activities of functional relevance for undifferentiated epithelial cells.

    ACKNOWLEDGEMENTS

We thank Dr. R. Burgeson (Cutaneous Biology Research Center, Charlestown, MA) for providing the purified human laminin-5, Drs. S. K. Akiyama (National Institute of Dental Research, Bethesda, MD) and E. Ruoslahti (The Burnham Institute, La Jolla, CA) for their generous gift of antibodies, Drs. J. Poisson and M. Lessard of the CUSE of Sherbrooke for their cooperation in providing specimens for this study, and Dr. P. H. Vachon for comments on the manuscript.

    FOOTNOTES

* This work was supported in part by Medical Research Council of Canada Group Grant GR-15186 and the "Fonds pour la Formation des Chercheurs et l'Aide à la Recherche" (FCAR).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Supported by a studentship from the Medical Research Council of Canada.

§ Supported by FCAR.

Supported by a studentship from the Université de Sherbrooke.

parallel To whom correspondence should be addressed: Dépt. d'anatomie et de biologie cellulaire, Faculté de médecine, Université de Sherbrooke, Sherbrooke, Québec, Canada J1H 5N4. Tel.: 819-564-5269; Fax: 819-564-5320; E-mail: jf.beaul@courrier.usherb.ca.

2 N. Basora and J. F. Beaulieu, unpublished data.

    ABBREVIATIONS

The abbreviations used are: PBS, phosphate-buffered saline; PAGE, polyacrylamide gel electrophoresis; RT-PCR, reverse transcriptase-polymerase chain reaction; bp, base pair(s).

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Rodirguez-Boulan, E., and Nelson, W. (1989) Science 245, 718-725[Abstract/Free Full Text]
2. Burgeson, R. E., Chiquet, M., Deutzmann, R., Ekblom, P., Engel, J., Kleinman, H., Martin, G. R., Meneguzzi, G., Paulsson, M., Sanes, J., Timpl, R., Tryggvason, K., Yamada, Y., and Yurchenco, P. D. (1994) Matrix Biol. 14, 209-211[CrossRef][Medline] [Order article via Infotrieve]
3. Wewer, U. M., and Engvall, E. (1994) Methods Enzymol. 245, 85-104[Medline] [Order article via Infotrieve]
4. Engvall, E., Earwicker, D., Haarparanta, T., Ruoslahti, E., and Sanes, J. R. (1990) Cell Regul. 1, 731-740[Medline] [Order article via Infotrieve]
5. Ruoslahti, E. (1991) J. Clin. Invest. 87, 1-5
6. Hynes, R. O. (1992) Cell 69, 11-25[CrossRef][Medline] [Order article via Infotrieve]
7. Sonnenberg, A. (1992) Pathol. Biol. 40, 773-778[Medline] [Order article via Infotrieve]
8. Mercurio, A. M. (1995) Trends Cell Biol. 5, 419-423[CrossRef][Medline] [Order article via Infotrieve]
9. Sheppard, D. (1996) BioEssays 18, 655-660[CrossRef][Medline] [Order article via Infotrieve]
10. Clark, E. A., and Brugge, J. S. (1995) Science 268, 233-239[Abstract/Free Full Text]
11. Miyamoto, S., Teramoto, H., Gutkind, J. S., and Yamada, K. M. (1996) J. Cell Biol. 135, 1633-1642[Abstract/Free Full Text]
12. Wayner, E., and Carter, W. G. (1987) J. Cell Biol. 105, 1873-1884[Abstract/Free Full Text]
13. Beaulieu, J.-F. (1997) Prog. Histochem. Cytochem. 31-4, 1-78
14. Suzuki, S., and Naitoh, Y. (1990) EMBO J. 9, 757-763[Medline] [Order article via Infotrieve]
15. Hogervost, F., Kuikman, I., Kr, Von dem Borne, A. E. G., and Sonnenberg, A. (1990) EMBO J. 9, 765-770[Medline] [Order article via Infotrieve]
16. Tamura, R. N., Cooper, H. M., Collo, G., and Quaranta, V. (1990) J. Cell Biol. 111, 1593-1604[Abstract/Free Full Text]
17. Mainiero, F., Pepe, A., Wary, K. K., Spinardi, L., Mohammadi, M., Schlessinger, J., and Giancotti, F. G. (1995) EMBO J. 14, 4470-4481[Medline] [Order article via Infotrieve]
18. Borradori, L., and Sonnenberg, A. (1996) Curr. Opin. Cell Biol. 8, 647-656[CrossRef][Medline] [Order article via Infotrieve]
19. Weaver, V. M., Peterson, O. W., Wang, F., Larabell, C. A., Briand, P., Damsky, C., and Bissell, M. J. (1997) J. Cell Biol. 137, 231-245[Abstract/Free Full Text]
20. Dowling, J., Yu, Q-C., and Fuchs, E. (1996) J. Cell Biol. 134, 559-572[Abstract/Free Full Text]
21. Van der Neut, R., Krimpenfort, P., Calafat, J., Neissen, C. M., and Sonnenberg, A. (1996) Nat. Genet. 13, 366-369[CrossRef][Medline] [Order article via Infotrieve]
22. Murgia, C., Blaikie, P., Kim, N., Dans, M., Petrie, H. T., and Giancotti, F. G. (1998) EMBO J. 17, 3940-3951[CrossRef][Medline] [Order article via Infotrieve]
23. Giancotti, F. G. (1996) J. Cell Sci. 109, 1165-1172[Medline] [Order article via Infotrieve]
24. Mainiero, F., Murgia, C., Wary, K. K., Curatola, A. M., Pepe, A., Blumemberg, M., Westwick, J. K., Der, C. J., and Giancotti, F. G. (1997) EMBO J. 16, 2365-2375[CrossRef][Medline] [Order article via Infotrieve]
25. Beaulieu, J.-F. (1999) Front. Bioscience 4, d310-d321
26. Leblond, C. P. (1981) Am. J. Anat. 160, 114-159[Medline] [Order article via Infotrieve]
27. Louvard, D., Kedinger, M., and Hauri, H.-P. (1992) Ann. Rev. Cell Biol. 8, 157-195[CrossRef]
28. Ménard, D., and Beaulieu, J.-F. (1994) in Membrane Physiopathology (Bkaily, G., ed) , pp. 319-341, Kluwer Academic Publisher, Norwell
29. Podolsky, D. K., and Babyatsky, M. W. (1995) in Textbook of Gastroenterology (Yamada, T., ed), 2nd Ed. , pp. 546-577, JB Lippincott, Philadelphia
30. Boyle, W. J., and Brenner, D. A. (1995) Curr. Opin. Gastroenterol. 11, 121-127
31. Beaulieu, J.-F., and Vachon, P. H. (1994) Gastroenterology 106, 829-839[Medline] [Order article via Infotrieve]
32. Simon-Assmann, P., Duclos, B., Orian-Rousseau, V., Arnold, C., Mathelin, C., Engvall, E., and Kedinger, M. (1994) Dev. Dyn. 201, 71-85[Medline] [Order article via Infotrieve]
33. Vachon, P. H., and Beaulieu, J.-F. (1995) Am. J. Physiol. 268, G857-G867[Abstract/Free Full Text]
34. De Archangelis, A., Neuville, P., Boukamel, R., Lefebvre, O., Kedinger, M., and Simon-Assmann, P. (1996) J. Cell Biol. 133, 417-430[Abstract/Free Full Text]
35. Beaulieu, J.-F. (1992) J. Cell Sci. 102, 427-436[Abstract/Free Full Text]
36. Perreault, N., Vachon, P. H., and Beaulieu, J.-F. (1995) Anat. Rec. 242, 242-250[CrossRef][Medline] [Order article via Infotrieve]
37. Vachon, P. H., Xu, H., Liu, L., Loechel, F., Hayashi, Y., Arahata, K., Reed, J. C., Wewer, U. M., and Engvall, E. (1997) J. Clin. Invest. 100, 1870-1881[Medline] [Order article via Infotrieve]
38. Basora, N., Vachon, P. H., Herring-Gillam, F. E., Perreault, N., and Beaulieu, J.-F. (1997) Gastroenterology 113, 1510-1521[CrossRef][Medline] [Order article via Infotrieve]
39. Leivo, I., Tani, T., Laitinen, L., Bruns, R., Kivilaakso, E., Lehto, V. P., Burgeson, R. E., and Virtanen, I. (1996) J. Histochem. Cytochem. 44, 1267-1277[Abstract]
40. Giancotti, F. G., Stepp, M. A., Suzuki, S., Engvall, E., and Ruoslahti, E. (1992) J. Cell Biol. 118, 951-959[Abstract/Free Full Text]
41. Perreault, N., and Beaulieu, J.-F. (1996) Exp. Cell Res. 224, 354-364[CrossRef][Medline]